Inhaler
Latest AstraZeneca AB Patents:
- Pharmaceutical composition
- Methods of treating chronic kidney disease with dapagliflozin
- Pharmaceutical compositions comprising (2S)-n-{(1S)-1-cyano-2-[4-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)phenyl]ethyl}-1,4-oxazepane-2-carboxamide
- Arginase inhibitors and methods of use thereof
- Conjugates comprising cleavable linkers
Description
FIG. 1 shows a perspective view of the inhaler from above in an open condition;
FIG. 2 shows a side elevation of the inhaler in an open condition;
FIG. 3 shows a side elevation of the inhaler in a closed condition;
FIG. 4 shows a side elevation of the inhaler in a closed condition for the side other than that of as shown in FIG. 3;
FIG. 5 shows a plan view of the inhaler in a closed condition;
FIG. 6 shows a front elevation of the inhaler; and,
FIG. 7 shows a rear elevation of the inhaler.
Claims
The ornamental design for an inhaler, as shown and described.
Referenced Cited
Patent History
Patent number: D480474
Type: Grant
Filed: Apr 29, 2002
Date of Patent: Oct 7, 2003
Assignee: AstraZeneca AB (Sodertalje)
Inventors: Nick Bowman (Royston), Patrick Campbell (Royston), Anders Geert-Jensen (Aarhus), Jørgen Rasmussen (Struer), Keld Sloth (Struer)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Fish & Richardson P.C.
Application Number: 29/159,830
Type: Grant
Filed: Apr 29, 2002
Date of Patent: Oct 7, 2003
Assignee: AstraZeneca AB (Sodertalje)
Inventors: Nick Bowman (Royston), Patrick Campbell (Royston), Anders Geert-Jensen (Aarhus), Jørgen Rasmussen (Struer), Keld Sloth (Struer)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Fish & Richardson P.C.
Application Number: 29/159,830
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)
International Classification: 2902;
International Classification: 2902;